Table 2.
Clinicopathological features of gastrointestinal hemangiomas
No. of cases | 25 | ||
Age | 42.92 ± 22.75 (0-75) | Preoperative diagnosis study | |
Sex | CT or CECT | 14 (56%) | |
Male | 14 (54%) | Colonoscopy, EGD, or EUS | 9 (36%) |
Female | 11 (44%) | VCE | 9 (36%) |
Location | DBE | 6 (24%) | |
Jejunum | 9 (36%) | MRI | 4 (16%) |
Ileum | 6 (24%) | Angiography | 2 (8%) |
Colorectum | 6 (24%) | Abdominal X-ray | 1 (4%) |
Stomach | 4 (16%) | Histology | |
Size | 7.44 ± 8.601 (0.3-32.5) | Cavernous hemangioma | 15 (68.2%) |
Main symptom | Capillary hemangioma | 3 (13.7%) | |
Melena | 11 (44%) | Racemose hemangioma | 2 (9.1%) |
Anemia | 7 (28%) | Hemolymphangioma | 1 (4.5%) |
Dizziness | 5 (20%) | Hemangiolymphangioma | 1 (4.5%) |
Abdominal distention or pain | 5 (20%) | Treatment | |
Rectal bleeding or Hematochezia | 5 (20%) | Operation | 20 (80%) |
Hematemesis | 2 (8%) | Endoscopy | 1 (4%) |
Fatigue or weakness | 2 (8%) | Medication (propranolol) | 1 (4%) |
Anorexia or postprandial bloating | 2 (8%) | Iron supplementation | 1 (4%) |
Palpitations or cold sweat | 1 (4%) | None | 2 (8%) |
Anus exhausting and defecating | 1 (4%) |
The size was the average value of the longitudinal, transverse, and axial lengths of the tumor.